Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesProfusa, Inc. Common Stock

Profusa, Inc. Common Stock

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.5432 USD 0.01 ( 1.67%)
Last update at 2026-11-09T15:07:00Z
VOLUME
9222
Market Cap
1.11M

Momentum Score

…

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.53
Low
0.54
High
52 Week Price Range
0.86
Low
750.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Profusa develops tissue-integrating biosensors—implantable hydrogel sensors with wireless readers—to enable continuous monitoring of interstitial oxygen and other biomarkers. Long-term growth drivers include rising demand for remote chronic care, successful clinical validation and regulatory approvals, and potential adoption across hospital and outpatient settings; investors may view exposure to a novel physiologic-sensing platform as attractive if the company translates clinical data into commercial products.
Key risks are early-stage clinical and regulatory uncertainty, absence of commercial revenue and likely need for additional financing, and execution and competitive-technology challenges that could impede market adoption.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.53
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-0.56
ROE
-
Net Debt
13.04M
ROCE
71.54%
Diluted EPS TTM
-651.50

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -35.82M -9.23M -10.28M -20.22M -10.31M
Net income -35.82M -9.23M -10.28M -20.22M -10.31M
Selling general administrative 24.90M 2.99M 4.08M 5.24M 4.77M
Reconciled depreciation - - - 0.72M 1.18M
Ebit - - - -13.95M -6.23M
Ebitda -30.73M -4.81M -6.00M -13.22M -5.05M
Depreciation and amortization - - - 0.72M 1.18M
Operating income -13.22M -4.50M -6.07M -11.14M -11.69M
Other operating expenses 13.22M 4.50M 6.07M 11.14M 11.69M
Interest expense 5.09M 4.42M 4.28M 6.27M 4.08M
Net interest income -5.09M -4.42M -4.28M -6.27M -4.08M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 13.22M 4.50M 6.07M 11.14M 11.69M
Total other income expense net -22.60M -4.73M -4.21M -9.08M 1.38M
Net income from continuing ops -35.82M -9.23M -10.28M -20.22M -10.31M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 3.77M 3.07M 1.89M 1.03M 11.36M
Other current assets 1.99M 0.07M 0.15M 0.08M 0.06M
Total liab 30.43M 122.28M 111.89M 100.80M 95.02M
Total stockholder equity -26.66M -119.20M -110.00M -99.77M -83.66M
Other current liab 6.02M 3.97M 2.35M 1.19M 2.59M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -160.78M -124.96M -115.73M -105.45M -85.23M
Cash 1.78M 0.19M 0.14M 0.08M 0.86M
Total current liabilities 22.26M 57.13M 46.74M 35.65M 21.61M
Net debt 13.04M 48.02M 40.25M 30.95M 23.16M
Short term debt 6.94M 48.21M 40.40M 31.03M 15.76M
Short long term debt 6.94M 48.21M 40.40M 31.03M 15.01M
Short long term debt total 14.81M 48.21M 40.40M 31.03M 24.02M
Other stockholder equity 134.12M 5.75M 5.73M 5.68M 1.57M
Total current assets 3.76M 0.26M 0.33M 0.16M 0.96M
Net receivables - - 0.04M 0.00M 0.04M
Long term debt 7.88M - - - 1.19M
Accounts payable 7.34M 4.95M 3.99M 3.43M 3.26M
Non currrent assets other 0.00M 2.81M 1.56M 0.87M 0.29M
Non current assets total 0.01M 2.81M 1.56M 0.87M 10.40M
Capital lease obligations - - - 0.00M 7.82M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -2.00M 0.00M -0.00M - -
Total cashflows from investing activities -2.01M - -0.00M - -
Net borrowings 9.56M 3.08M 5.06M 7.70M 8.70M
Total cash from financing activities 19.84M 2.12M 4.47M 6.92M 8.75M
Net income -35.82M -9.23M -10.28M -20.22M -10.31M
Change in cash 1.59M 0.05M 0.06M -0.78M -1.94M
Begin period cash flow 0.19M 0.14M 0.08M 0.86M 2.80M
End period cash flow 1.78M 0.19M 0.14M 0.08M 0.86M
Total cash from operating activities -16.25M -2.07M -4.40M -7.70M -10.69M
Depreciation - - - 0.72M 1.18M
Change to account receivables - 0.04M -0.04M 0.04M 0.37M
Other cashflows from financing activities 10.28M -0.96M -0.59M -0.77M 0.05M
Capital expenditures 0.01M 0.00M 0.00M 0.00M 0.00M
Change in working capital 4.35M 2.41M 1.54M 0.91M -0.52M
Stock based compensation 0.89M 0.02M 0.03M 0.11M 0.07M
Other non cash items 14.34M 4.74M 4.30M 10.77M -1.11M
Free cash flow -16.26M -2.07M -4.40M -7.70M -10.69M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
PFSA
Profusa, Inc. Common Stock		 0.01
1.67%		 0.54 - - 104.68 -
ABT
Abbott Laboratories		 -0.36
0.33%		 109.56 25.97 17.24 3.57 3.20
MDT
Medtronic PLC		 -0.14
0.14%		 101.66 26.60 15.87 3.35 2.08
SYK
Stryker Corporation		 -0.84
0.26%		 325.03 29.23 16.86 4.18 4.51
SEMHF
Siemens Healthineers AG		 0.56
1.12%		 50.41 39.57 21.32 3.01 3.29

Profile*

Profusa, Inc. Common Stock

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

626 Bancroft Way, Berkeley, CA, United States, 94710

925 997 6925

https://profusa.com

Name Title Year Born
Dr. Chung-Bin Hwang Ph.D. President 1968
Mr. Fred S. Knechtel Chief Financial Officer 1961
Mr. Jack E. Stover CPA CEO & Executive Chairman 1953
Mr. William McMillan Co-founder, Chief Scientific Officer & Head of Research 1951
Mr. David Icke Head of Digital Health Business NA
Mr. Sean Givens Head of Government Business NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.96
+38.15%
MOON
CAD 4.83
+9.64%
PDN
CAD 8.13
+7.68%
BDT
CAD 72.82
+6.65%
HG
CAD 4.28
+6.20%
CSU
CAD 3300.00
-6.42%
CURA
CAD 12.68
-4.16%
DIV
CAD 3.93
-3.44%
SOIL
CAD 7.18
-3.10%
OBE
CAD 13.31
-2.92%

Equity Sectors*

  • Basic Materials

    +3.19%

  • Communication Services

    -0.04%

  • Consumer Cyclical

    +0.27%

  • Consumer Defensive

    -0.21%

  • Energy

    +1.16%

  • Financial Services

    +0.81%

  • Healthcare

    +0.03%

  • Industrials

    +1.64%

  • Real Estate

    +0.06%

  • Technology

    +0.38%

  • Utilities

    +0.68%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…